JP2018520647A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520647A5
JP2018520647A5 JP2017558986A JP2017558986A JP2018520647A5 JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5 JP 2017558986 A JP2017558986 A JP 2017558986A JP 2017558986 A JP2017558986 A JP 2017558986A JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5
Authority
JP
Japan
Prior art keywords
composition
enzyme
biological sample
inactivating
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558986A
Other languages
English (en)
Japanese (ja)
Other versions
JP7044554B2 (ja
JP2018520647A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/060263 external-priority patent/WO2016180747A1/en
Publication of JP2018520647A publication Critical patent/JP2018520647A/ja
Publication of JP2018520647A5 publication Critical patent/JP2018520647A5/ja
Application granted granted Critical
Publication of JP7044554B2 publication Critical patent/JP7044554B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558986A 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法 Active JP7044554B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562159297P 2015-05-10 2015-05-10
US62/159,297 2015-05-10
PCT/EP2016/060263 WO2016180747A1 (en) 2015-05-10 2016-05-09 Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205107A Division JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Publications (3)

Publication Number Publication Date
JP2018520647A JP2018520647A (ja) 2018-08-02
JP2018520647A5 true JP2018520647A5 (enExample) 2019-05-30
JP7044554B2 JP7044554B2 (ja) 2022-03-30

Family

ID=55953158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017558986A Active JP7044554B2 (ja) 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Country Status (7)

Country Link
US (3) US11162877B2 (enExample)
EP (1) EP3295173B1 (enExample)
JP (2) JP7044554B2 (enExample)
CN (1) CN107980095A (enExample)
AU (1) AU2016261279B2 (enExample)
CA (1) CA2984701C (enExample)
WO (1) WO2016180747A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7455816B2 (ja) 2018-09-20 2024-03-26 ヴェンタナ メディカル システムズ, インク. クマリン系架橋試薬
EP3904383A4 (en) 2018-12-25 2022-08-17 Hanx Biopharmaceutics, Inc ANTI-OX40 MONOCLONAL ANTIBODY AND USE THEREOF
CN116783485A (zh) 2021-01-15 2023-09-19 文塔纳医疗系统公司 储存稳定的笼状半抗原
JP2024507677A (ja) 2021-01-25 2024-02-21 ベンタナ メディカル システムズ, インコーポレイテッド 1つ又は複数の検出可能部分で標識された1つ又は複数のバイオマーカーを含む染色された生物学的検体
US20240177633A1 (en) 2021-03-30 2024-05-30 Sato Holdings Kabushiki Kaisha Label structure and label
WO2022223137A1 (en) 2021-04-18 2022-10-27 Ventana Medical Systems, Inc. Morphological marker staining
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
CN120359417A (zh) 2022-12-23 2025-07-22 文塔纳医疗系统公司 用于评估抗原呈递机制组分的材料和方法及其用途
WO2025014787A1 (en) 2023-07-07 2025-01-16 Ventana Medical Systems, Inc. Brightfield triplex immunohistochemistry assay for evaluating the colocalization of the er, pr, and ki-67 biomarkers in cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410400C2 (de) * 1984-03-21 1987-04-02 Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg Kontaktlinsenpflegesatz und Verfahren zur Pflege von Kontaktlinsen
US5225325A (en) * 1990-03-02 1993-07-06 Ventana Medical Systems, Inc. Immunohistochemical staining method and reagents therefor
US5595707A (en) 1990-03-02 1997-01-21 Ventana Medical Systems, Inc. Automated biological reaction apparatus
CN1282422A (zh) * 1997-10-21 2001-01-31 癌症研究行动技术有限公司 对细胞生长异常的测定
AU763354B2 (en) 1998-02-27 2003-07-17 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US20030211630A1 (en) 1998-02-27 2003-11-13 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
US6582962B1 (en) 1998-02-27 2003-06-24 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
SE9804064D0 (sv) 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
US20050176072A1 (en) * 2002-06-21 2005-08-11 Martin Michelle D. MTA1 is a predictive and prognostic factor in human breast cancer
US20040248223A1 (en) * 2003-06-05 2004-12-09 Idexx Laboratories, Inc. Reduction of interfering peroxidase activity in peroxidase based detection methods
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
JP5733734B2 (ja) * 2009-02-19 2015-06-10 国立大学法人 千葉大学 成長因子に誘発されるユークロマチン化(euchromatinization)に必要な、SRC−ファミリーチロシンキナーゼの核局在
EP3061463A1 (en) * 2009-04-08 2016-08-31 LipUm AB New methods for treatment of inflammatory diseases
EP2993478B1 (en) 2009-10-19 2022-08-24 Ventana Medical Systems, Inc. Device and method for slide caching
US9920324B2 (en) * 2011-06-01 2018-03-20 Intrexon Actobiotics Nv Polycistronic expression system for bacteria
SG2014011084A (en) 2011-09-09 2014-04-28 Ventana Med Syst Inc Imaging systems, cassettes, and methods of using the same
WO2013148498A1 (en) 2012-03-27 2013-10-03 Ventana Medical Systems, Inc. Signaling conjugates and methods of use

Similar Documents

Publication Publication Date Title
JP2018520647A5 (enExample)
Lu et al. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance
Turner et al. Cloning and characterization of two NAD kinases from Arabidopsis. Identification of a calmodulin binding isoform
Zhang et al. Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT)
Wilson et al. Ubiquitylation and degradation of elongating RNA polymerase II: the last resort
Bianchi et al. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
Sultan et al. During the early stages of Staphylococcus aureus biofilm formation, induced neutrophil extracellular traps are degraded by autologous thermonuclease
BR112019019087A2 (pt) Diagnóstico baseado em sistema efetor de crispr para detecção de vírus
Zhang et al. Low long non-coding RNA HOTAIR expression is associated with down-regulation of Nrf2 in the spermatozoa of patients with asthenozoospermia or oligoasthenozoospermia
Crinelli et al. Palytoxin and an Ostreopsis toxin extract increase the levels of mRNAs encoding inflammation-related proteins in human macrophages via p38 MAPK and NF-κB
Kuczyńska-Wiśnik et al. Escherichia coli heat-shock proteins IbpA and IbpB affect biofilm formation by influencing the level of extracellular indole
Pruneski et al. The Paf1 complex represses SER3 transcription in Saccharomyces cerevisiae by facilitating intergenic transcription-dependent nucleosome occupancy of the SER3 promoter
Cucinotta et al. The nucleosome acidic patch regulates the H2B K123 monoubiquitylation cascade and transcription elongation in Saccharomyces cerevisiae
Hartmann et al. Murein Hydrolases in the Envelope of Escherichia coli: Properties in situ and Solubilization from the Envelope
EP2495316A3 (en) Desizing and scouring process of starch
Pérez-Mendoza et al. N-Acetylglucosamine-dependent biofilm formation in Pectobacterium atrosepticum is cryptic and activated by elevated c-di-GMP levels
Sirikharin et al. Role of astakine1 in regulating transglutaminase activity
Liberio et al. The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases
EP3215630A1 (en) Analytical and diagnostic methods utilizing shigella flexneri apyrase
Ragu et al. Loss of the thioredoxin reductase Trr1 suppresses the genomic instability of peroxiredoxin tsa1 mutants
Ullmann et al. Comparative clinical sample preparation of DNA and RNA viral nucleic acids for a commercial deep sequencing system (Illumina MiSeq®)
Torres-Huerta et al. Characterization of recombinase DMC1B and its functional role as Rad51 in DNA damage repair in Giardia duodenalis trophozoites
Broglia et al. RNase Y-mediated regulation of the streptococcal pyrogenic exotoxin B
JP2016509835A5 (enExample)
Liang et al. Divergence of TORC1-mediated stress response leads to novel acquired stress resistance in a pathogenic yeast